文献
J-GLOBAL ID:202002255997138483
整理番号:20A0484210
フルダラビン,低用量シクロホスファミドおよび低用量チモグロブリンを用いた移植前コンディショニングによる再生不良性貧血に対する同種造血幹細胞移植: KSGCT前向き研究【JST・京大機械翻訳】
Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective study
著者 (23件):
Kako Shinichi
(Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan)
,
Kanda Yoshinobu
(Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan)
,
Onizuka Makoto
(Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan)
,
Aotsuka Nobuyuki
(Division of Hematology-Oncology, Japanese Red Cross Society Narita Hospital, Chiba, Japan)
,
Usuki Kensuke
(Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan)
,
Tachibana Takayoshi
(Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan)
,
Kobayashi Takeshi
(Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan)
,
Kato Jun
(Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan)
,
Yano Shingo
(Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan)
,
Shimizu Hiroaki
(Department of Medicine and Clinical Science, Gunma University, Gunma, Japan)
,
Shono Katsuhiro
(Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan)
,
Tanaka Masatsugu
(Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan)
,
Tsukamoto Shokichi
(Department of Hematology, Chiba University Hospital, Chiba, Japan)
,
Mori Takehiko
(Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan)
,
Yamazaki Etsuko
(Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Kanagawa, Japan)
,
Najima Yuho
(Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan)
,
Hangaishi Akira
(Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan)
,
Hoshino Takumi
(Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma, Japan)
,
Watanabe Reiko
(Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan)
,
Matsumoto Kenji
(Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan)
,
Matsumoto Kenji
(Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Kanagawa, Japan)
,
Okamoto Shinichiro
(Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan)
,
for Kanto Study Group for Cell Therapy (KSGCT)
資料名:
American Journal of Hematology
(American Journal of Hematology)
巻:
95
号:
3
ページ:
251-257
発行年:
2020年
JST資料番号:
E0721B
ISSN:
0361-8609
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)